Minuscule particles with the ability to cross hard-to-penetrate barriers can be loaded with drug treatments to target intractable diseases.

This story was originally published by CalMatters. Sign up for their newsletters. Guest Commentary written by Mary E. Brown ...

Watching for early signs and symptoms of a sickle cell crisis allows columnist Oluwatosin Adesoye to initiate timely ...

A renewed push to find a lasting solution to sickle cell disease is gaining momentum, with key institutions joining forces to ...

Nemours Children's Hospital is now offering Lyfgenia gene therapy. The treatment aims to reduce pain crises and hospital ...

Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the ...

He is the first person in the state to receive LYFGENIA, a one-time gene therapy designed to keep the red blood cells that ...

KiKi Shepard was a co-host of the music showcase "Showtime at the Apollo," which filmed at Harlem's famous Apollo Theater.

Abstract: Prevention of irreversible impairment of vision and access to prompt medical treatment is highly supported by the timely diagnosis of severe ocular conditions. In this paper, the mechanism ...

President Donald Trump hailed the swift prosecution of the military campaign against Iran, but acknowledged there are terrorist "sleeper cells" in the U.S. that have to be watched and dealt with.

In a new study published in Cell Death & Disease, a team of researchers from the University of Michigan found functional ...